[ad_1]
Company’s decision to price its Covid-19 vaccine at $110-$130 per dose seeks to make up for lower demand for boosters
[ad_2]
Source link
By admin
0 Comment
#analysts' comments #Analysts' Comments/Recommendations #Biotechnology #C&E Exclusion Filter #Content Types #corporate #Corporate/Industrial News #epidemics #Factiva Filters #general news #health #healthcare #Healthcare/Life Sciences #Immunizations #industrial news #Infectious Diseases #JPM #JPMorgan Chase & #life sciences #Medical Conditions #medical treatments #Medical Treatments/Procedures #medications #moderna #MRNA #Novel Coronaviruses #Oppenheimer Holdings #OPY #outbreaks #Outbreaks/Epidemics #PFE #pfizer #Pharmaceuticals #political #Political/General News #procedures #recommendations #Respiratory Tract Diseases #SIVB #specialized drugs #Specialized Drugs/Medications #SVB Financial Group #SYND #Vaccines #WSJ-PRO-WSJ.com
[ad_1]
[ad_2]
Source link
The VyVyMangaa.Com